Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Change in Receivables (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Change in Receivables for 11 consecutive years, with $482930.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Receivables rose 170.88% to $482930.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $247301.0, a 80.57% decrease, with the full-year FY2024 number at $1.7 million, up 244.53% from a year prior.
  • Change in Receivables was $482930.0 for Q3 2025 at KORU Medical Systems, up from -$1.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $1.2 million in Q2 2024 to a low of -$1.5 million in Q4 2022.
  • A 5-year average of $149423.6 and a median of $470221.0 in 2021 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: soared 433.8% in 2021, then tumbled 829.65% in 2024.
  • KORU Medical Systems' Change in Receivables stood at $470221.0 in 2021, then plummeted by 414.55% to -$1.5 million in 2022, then soared by 110.37% to $153352.0 in 2023, then skyrocketed by 262.6% to $556050.0 in 2024, then decreased by 13.15% to $482930.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Change in Receivables are $482930.0 (Q3 2025), -$1.0 million (Q2 2025), and $228661.0 (Q1 2025).